Home > Journals > Minerva Biotecnologica > Past Issues > Minerva Biotecnologica 2005 September;17(3) > Minerva Biotecnologica 2005 September;17(3):107-17

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  MEDICINAL PLANTS FOR BIOTECHNOLOGY AND BIOMEDICINE 

Minerva Biotecnologica 2005 September;17(3):107-17

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: English

Oligosaccharides engineering from plants and algae applications in biotechnology and therapeutics

Delattre C., Michaud P., Courtois B., Courtois J.

Laboratory of Glucides-EPMV CNRS FRE 2779, IUT/GB, UPJV, Amiens, France


Full text temporarily not available online. Contact us


Since the last decade, newly observed functions of oligosaccharides are their ability to act as regulatory molecules on various organisms. The successful development of these compounds in future implies efficient processes for specific oligosaccharide production. For this reason, plant and algae constitute an original source of various oligosaccharidic structures. To exploit them, two strategies are available: synthesis (chemical or by enzymes) and polysaccharide cleavage (chemical, physical or biological). This review catalogues the possibilities of these methods, applied to plant and algae polysaccharide models, to generate bioactive oligosaccharides.

top of page